Task: Answer the multiple-choice question.
Query: Which drug has a -42.110% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a COc1ccc(CCN2C(=NC(=O)CC(C)C)SC3CS(=O)(=O)CC32)cc1
b CCC(=O)Oc1ccc(-c2cnc3ccccc3n2)cc1
c O=C(CC(c1ccccc1)c1cc(Cl)ccc1O)NCCN1CCOCC1
Answer: c. O=C(CC(c1ccccc1)c1cc(Cl)ccc1O)NCCN1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CC(c1ccccc1)c1cc(Cl)ccc1O)NCCN1CCOCC1
O=C(CC(c1ccccc1)c1cc(Cl)ccc1O)NCCN1CCOCC1
3-(5-chloro-2-hydroxyphenyl)-N-(2-morpholin-4-ylethyl)-3-phenylpropanamide